ErectiStim Technology

ErectiStim also combines bioelectrical therapy for improving muscle performance. It is our belief that BOTH are essential for long-term erectile dysfunction recovery.

Most other erectile dysfunction therapies focus only on improving blood circulation. ErectiStim also combines bioelectrical therapy for improving muscle performance. It is our belief that BOTH are essential for long-term erectile dysfunction recovery.

Elevated myostatin levels have been implicated in numerous muscle disorders including penile erectile dysfunction. In these conditions, inhibition of the myostatin pathway represents an alternative strategy to improve functional outcomes. Preclinical data that support this approach clearly demonstrate the potential for blocking the myostatin pathway. Follistatin has emerged as a powerful antagonist of myostatin that can increase penile and other muscle mass and strength. Follistatin was first isolated from the ovary and is known to suppress follicle-stimulating hormone. ErectiStim has precise bioelectric signaling sequences that have demonstrated an ability to control release of the follistatin protein in penile tissue on demand.

Current Electrode

Current Portable Device

Future Portable Device Look

MyoStim ED has developed 2 products for treating erectile dysfunction.
7

ErectiStim™

bioelectric non-invasive stimulation for blood flow, muscle and nerve regeneration as well as neurohormonal balancing.
7

ErectiStim Plus™

bioelectric and biologics* injections or infusions for treatment of the more serious cases of erectile dysfunction.
* Biologics – the MyoStim ED ErectiStim Plus™ biologics composition may include any or all of these components or any combination thereof – stem cells, stromal fraction from adipose tissue, exosomes, amniotic fluid, PRF, micro RNA gel, oxygenated nanoparticles, selected growth factors such as follistatin, klotho, SDF1, PDGF and tropoelastin, nutrient hydrogel, Wharton’s jelly, matrix.
“Most other erectile dysfunction therapies focus only on improving blood circulation.”